Estimating the Prevalence of GAstrocnemius Muscle REtraction in a Population Suffering From Plantar aPOneurositis and Describing the Effects of Lengthening
REGAPOP
2 other identifiers
interventional
100
0 countries
N/A
Brief Summary
The gastrocnemius muscles, which form the upper part of the calf, can suffer from retraction, a common but often under-diagnosed condition, which can be a risk factor for plantar fasciitis. Retraction can be treated medically, by stretching, or surgically, by lengthening the muscles. Gastrocnemius retraction is difficult to measure, but tests such as the Ankle Dorsiflexion Index (ADI) provide a more accurate assessment. Knowing the prevalence of this retraction in patients suffering from plantar fasciitis would enable us to improve diagnostic criteria and better target treatments. Surgical lengthening of the gastrocnemius, particularly by tenotomy, is effective in cases of chronic plantar fasciitis, even without apparent muscle retraction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
July 11, 2025
July 1, 2025
3.5 years
June 23, 2025
July 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of gastrocnemius muscle retraction in patients with plantar fasciitis
retraction of the gastrocnemius muscles will be defined by an ADI of less than 13° measured by a digital inclinometer
At Day 0
Secondary Outcomes (12)
correlation between ADI measurement and Manchester Oxford Foot Questionnaire (MOXFQ)
At Day 0
correlation between ADI measurement and pain Visual Analog Scale (VAS)
At Day 0
Evolution of Visual Analog Scale (VAS)
between Day 0 and Week 8
Evolution of Visual Analog Scale (VAS)
between Day 0 and Week 16
Evolution of Visual Analog Scale (VAS)
between Day0 and Week 24
- +7 more secondary outcomes
Study Arms (1)
Ankle Dorsiflexion Index (ADI) measurement
EXPERIMENTALAnkle Dorsiflexion Index (ADI) measurement at D0 and W8
Interventions
Ankle Dorsiflexion Index (ADI) measurement at D0 and W8
Eligibility Criteria
You may qualify if:
- Patient aged 70 or under
- Patient suffering from unilateral plantar fasciitis that has progressed for more than 6 months and is recalcitrant to medical treatment
- Collection of express, oral consent
- Available for follow-up visits
You may not qualify if:
- Patients with neuropathic pain
- History of fracture of the lower limb, surgery on the lower limb, inflammatory rheumatism of the lower limb, injury to the Achilles tendon
- Patient with another painful orthopedic lesion of the legs/feet
- Persons unable to give consent
- Not affiliated to a social security scheme
- Persons under court protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 11, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
March 1, 2029
Last Updated
July 11, 2025
Record last verified: 2025-07